The FDA Panel Weighs In on Trendy Peptide Therapies

peptides FDA wellness

En resumen

An FDA panel is set to review seven peptides, popular in wellness circles for injury recovery and more, but lacking large-scale trials and FDA approval.
Concerns linger about safety and potential conflicts of interest among panel members.

Resumen generado por IA

Tamaño de fuente

An FDA panel is set to review seven peptides, popular in wellness circles for injury recovery and more, but lacking large-scale trials and FDA approval. Concerns linger about safety and potential conflicts of interest among panel members.

Read the full article on NPR News

Temas relacionados

peptides

TemasFDA wellness sports medicine compounding pharmacies drug approval GLP-1 drugs

This article was originally published by NPR News.

Noticias relacionadas

Más sobre este temapeptides

En desarrollo·15 sa önce

Surgeons Performing Euthanasia by Organ Removal: A Controversial Proposal

A proposal called "Death by Organ Donation" suggests surgeons could remove organs from euthanasia patients while alive, making organs more viable for transplant. This idea, supported by some bioethicists, faces strong opposition due to ethical concerns and potential damage to trust in end-of-life care and organ donation systems.

NPR News

En desarrollo·15 sa önce

Michigan Faces Largest Cyclospora Outbreak in State History

Michigan reports nearly 1,000 cases of parasitic infection, the largest outbreak in state history. Investigations are ongoing in 28 other states, with Ohio also reporting hundreds of cases. The source remains unidentified, and the illness, cyclosporiasis, causes prolonged diarrhea.

ABC News

En desarrollo·1 g önce

Michigan Sees Exploding Diarrhea Outbreak With No Clear Source

Michigan is experiencing a significant outbreak of cyclosporiasis, a diarrhea-causing illness, with over 700 cases reported since June 22. Despite 36 hospitalizations, the source of the parasitic infection remains unidentified, prompting a large-scale investigation involving state and federal health agencies.

Ars Technica

En desarrollo·1 g önce

Study Reveals High Prevalence of Red Meat Allergy Antibody, Raising Diagnostic Concerns

A new study found up to 30% of people in some US regions carry the antibody linked to a red meat allergy triggered by tick bites, far exceeding the estimated number of diagnosed cases. This suggests widespread asymptomatic sensitization and raises concerns about overdiagnosis.

Ars Technica

En desarrollo·1 g önce

How Scientists Identify Potential Pandemic Viruses

Scientists are developing methods to predict which newly discovered viruses could cause public health emergencies. By analyzing historical data on RNA viruses, transmissibility, and disease severity, researchers aim to identify potential pandemic threats like "disease X" before they spread widely.

Ars Technica

En desarrollo·1 g önce

New Treatments and Prevention Methods Tested in DRC and Uganda Ebola Outbreak

Over 50 days into the Ebola outbreak in DRC and Uganda, clinical trials are underway for new treatments against the rarer Bundibugyo virus. Two drugs, remdesivir and MBP-134, are being tested for treatment, while obeldesivir is being studied for post-exposure prevention. The trials face challenges including ongoing conflict and community mistrust.

NPR News

Más sobre este temapeptides